Exact Mass: 522.3304846

Exact Mass Matches: 522.3304846

Found 71 metabolites which its exact mass value is equals to given mass value 522.3304846, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Polysorbate 20

2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate

C26H50O10 (522.34038)


Polysorbate 20 is an emulsifier, dough improver, crystallisation retarder, solubiliser, stabiliser, flavour dispersant, wetting agent, fruit or vegetable coating, defoamer for yeast/sugar.Polysorbates are a class of emulsifiers used in some pharmaceuticals and food preparation. They are often used in cosmetics to solubilize essential oils into water-based products. Polysorbates are oily liquids derived from PEG-ylated sorbitan (a derivative of sorbitol) esterified with fatty acids. (Wikipedia). Emulsifier, stabiliser, flavouring agent, dispersant

   

Metabolite M6

(2R)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-C-hydroxycarbonimidoyl}butyl]-N-tert-butylpiperazine-2-carboximidic acid

C30H42N4O4 (522.3205892)


Metabolite M6 is a metabolite of indinavir. Indinavir (IDV; trade name Crixivan, manufactured by Merck) is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART) to treat HIV infection and AIDS. (Wikipedia)

   

PA(10:0/13:0)

[(2R)-3-(decanoyloxy)-2-(tridecanoyloxy)propoxy]phosphonic acid

C26H51O8P (522.3321376)


PA(10:0/13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/13:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of tridecylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/15:0)

[(2R)-3-(octanoyloxy)-2-(pentadecanoyloxy)propoxy]phosphonic acid

C26H51O8P (522.3321376)


PA(8:0/15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/15:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(10:0/a-13:0)

[(2R)-3-(decanoyloxy)-2-[(10-methyldodecanoyl)oxy]propoxy]phosphonic acid

C26H51O8P (522.3321376)


PA(10:0/a-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/a-13:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(10:0/i-13:0)

[(2R)-3-(decanoyloxy)-2-[(11-methyldodecanoyl)oxy]propoxy]phosphonic acid

C26H51O8P (522.3321376)


PA(10:0/i-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-13:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/a-15:0)

[(2R)-2-[(12-methyltetradecanoyl)oxy]-3-(octanoyloxy)propoxy]phosphonic acid

C26H51O8P (522.3321376)


PA(8:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/a-15:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/i-15:0)

[(2R)-2-[(13-methyltetradecanoyl)oxy]-3-(octanoyloxy)propoxy]phosphonic acid

C26H51O8P (522.3321376)


PA(8:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-15:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

Cholylasparagine

3-carbamoyl-2-(4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)propanoic acid

C28H46N2O7 (522.3304846)


Cholylasparagine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylasparagine consists of the bile acid cholic acid conjugated to the amino acid Asparagine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylasparagine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylasparagine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Polysorbate 80

2-{2-[(2R,3R)-3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate

C26H50O10 (522.34038)


Emulsifier, surfactant in production of coarse cryst. NaCl, stabiliser, wetting agent in poultry scalds, colour diluent, flavour. Polysorbate 80 is a nonionic surfactant and emulsifier derived from polyethoxylated sorbitan and oleic acid, and is often used in foods. Polysorbate 80 is a viscous, water-soluble yellow Liquid. Emulsifier, surfactant in production of coarse cryst. NaCl, stabiliser, wetting agent in poultry scalds, colour diluent, flavour

   

(-)-(S)-isoverbasitrine

(-)-(S)-isoverbasitrine

C30H42N4O4 (522.3205892)


   

[3,4,6-Trihydroxy-6-[2-(1,3-oxazol-5-ylmethyl)-1,3-oxazol-4-yl]hexan-2-yl] pentadecanoate

[3,4,6-Trihydroxy-6-[2-(1,3-oxazol-5-ylmethyl)-1,3-oxazol-4-yl]hexan-2-yl] pentadecanoate

C28H46N2O7 (522.3304846)


   
   

methyl (13Z,15E,17E,22E)-3beta-acetoxy-12-oxomalabarica-13,15,17,22,24-pentaen-28-oate

methyl (13Z,15E,17E,22E)-3beta-acetoxy-12-oxomalabarica-13,15,17,22,24-pentaen-28-oate

C33H46O5 (522.3345065999999)


   
   
   
   

Asparagine conjugated cholic acid

Asparagine conjugated cholic acid

C28H46N2O7 (522.3304846)


   

((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycylglycine

"((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycylglycine"

C28H46N2O7 (522.3304846)


   

N-depyridomethyl-Indinavir

N-depyridomethyl-Indinavir

C30H42N4O4 (522.3205892)


   

Alkest TW 20

2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate

C26H50O10 (522.34038)


D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D013501 - Surface-Active Agents > D011136 - Polysorbates D001697 - Biomedical and Dental Materials

   

bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] adipate

bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] adipate

C26H50O10 (522.34038)


   

Tween 20

Tween 20

C26H50O10 (522.34038)


D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D013501 - Surface-Active Agents > D011136 - Polysorbates D001697 - Biomedical and Dental Materials

   
   

N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C30H42N4O4 (522.3205892)


   

N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C30H42N4O4 (522.3205892)


   

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C30H42N4O4 (522.3205892)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C30H42N4O4 (522.3205892)


   

N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C30H42N4O4 (522.3205892)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C30H42N4O4 (522.3205892)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C30H42N4O4 (522.3205892)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C30H42N4O4 (522.3205892)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C30H42N4O4 (522.3205892)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C30H42N4O4 (522.3205892)


   

((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycylglycine

((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycylglycine

C28H46N2O7 (522.3304846)


   

2,3-dihydroxypropyl [2-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propyl] hydrogen phosphate

2,3-dihydroxypropyl [2-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propyl] hydrogen phosphate

C26H51O8P (522.3321376)


   

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) icosanoate

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) icosanoate

C26H51O8P (522.3321376)


   

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate

C26H51O8P (522.3321376)


   

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C26H51O8P (522.3321376)


   

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate

C26H51O8P (522.3321376)


   

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate

C26H51O8P (522.3321376)


   

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

C26H51O8P (522.3321376)


   

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

C26H51O8P (522.3321376)


   

(1-Acetyloxy-3-phosphonooxypropan-2-yl) henicosanoate

(1-Acetyloxy-3-phosphonooxypropan-2-yl) henicosanoate

C26H51O8P (522.3321376)


   

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) dodecanoate

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) dodecanoate

C26H51O8P (522.3321376)


   

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate

C26H51O8P (522.3321376)


   

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] dodecanoate

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] dodecanoate

C26H51O8P (522.3321376)


   

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] tridecanoate

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] tridecanoate

C26H51O8P (522.3321376)


   

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] dodecanoate

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] dodecanoate

C26H51O8P (522.3321376)


   

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] 10-methyldodecanoate

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] 10-methyldodecanoate

C26H51O8P (522.3321376)


   

[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] pentadecanoate

[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] pentadecanoate

C26H51O8P (522.3321376)


   

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] tridecanoate

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] tridecanoate

C26H51O8P (522.3321376)


   
   
   
   
   
   
   
   
   
   
   

LPG P-20:1 or LPG O-20:2

LPG P-20:1 or LPG O-20:2

C26H51O8P (522.3321376)


   
   
   
   
   
   
   

(2e)-3-(3,4-dimethoxyphenyl)-1-[(8s)-6-hydroxy-8-phenyl-1,5,9,13-tetraazacycloheptadec-5-en-1-yl]prop-2-en-1-one

(2e)-3-(3,4-dimethoxyphenyl)-1-[(8s)-6-hydroxy-8-phenyl-1,5,9,13-tetraazacycloheptadec-5-en-1-yl]prop-2-en-1-one

C30H42N4O4 (522.3205892)


   

(1s,3r,7r,8s,10r)-7-methyl-1,8,10-tris(3-methylbut-2-en-1-yl)-2,11,13-trioxo-4-(sec-butyl)-12-oxatricyclo[8.2.1.0³,⁷]tridec-4-ene-5-carbaldehyde

(1s,3r,7r,8s,10r)-7-methyl-1,8,10-tris(3-methylbut-2-en-1-yl)-2,11,13-trioxo-4-(sec-butyl)-12-oxatricyclo[8.2.1.0³,⁷]tridec-4-ene-5-carbaldehyde

C33H46O5 (522.3345065999999)